Evaluation of demographic and clinical characteristics of healthcare professionals with COVID-19 in Northwest Syria Region

Seyhan, Avni Uygar; Karaca, Bahadır

doi:10.5505/turkhijyen.2020.02212

Cited by 6 publications

(5 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…As a result, patients were deprived of transplantation benefits, and waiting list numbers increased during the pandemic (18). Moreover, the transmission of the virus to healthcare professionals disturbed medical facilities' performance (19).…”

Section: Discussionmentioning

confidence: 99%

“…Coronavirus Disease 2019 (COVID- 19) was initially identified in Wuhan, China in December 2019, and is caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection (1). The virus soon spread worldwide, and the World Health Organization (WHO) declared COVID-19 a Public Health Emergency of International Concern on January 30, 2020 (2).…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Dialysis Requirements of Kidney Transplant Recipients During COVID-19

Uysal¹

2023

J Clin Pract Res

View full text Add to dashboard Cite

Objective: The complications of Coronavirus Disease 2019 have increased among kidney transplant recipients (KTR) due to chronic immunosuppression and comorbidities. Additionally, acute kidney injury (AKI) is frequently observed during COVID-19. This study aimed to investigate the impact of COVID-19 on kidney allograft survival. Materials and Methods:The retrospective, single-center investigation study included 88 patients who had a functioning kidney allograft prior to COVID-19 diagnosis. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection was confirmed with a polymerase chain reaction (PCR) test and thoracic computerized tomography. AKI and dialysis requirements were analyzed using laboratory, demographic, and clinical parameters. Results:The median age of the patients was 44.5 (34.3-53.8) years, and the median allograft survival was 59.0 (20.8-116.5) months. The mean baseline estimated glomerular filtration rate (eGFR) was 58.2 (21.2-92.8) ml/min/1.73 m 2 before the COVID-19 diagnosis. The frequency of AKI was 70.4% (62 patients), and dialysis therapy was required in nine patients (10.2%). The clinical features of COVID-19 and inflammatory markers had no statistical significance in predicting dialysis requirements. However, logistic regression analysis indicated that serum protein level (p=0.034), serum albumin level (p=0.048), hemoglobin (p=0.028), baseline eGFR (p=0.033), and age (p=0.041) were significantly predictive for dialysis requirements. Conclusion:Age, anemia, and decreased baseline eGFR are related to severe AKI and dialysis therapy in KTR during COVID-19.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Dialysis Requirements of Kidney Transplant Recipients During COVID-19

Uysal¹

2023

J Clin Pract Res

View full text Add to dashboard Cite

show abstract

“…Indeed, 25 physicians and 47 nurses and a total of 260 healthcare workers were vaccinated over two months. Studies by Seyhan et al state that there are more than 4.000 health workers in the northwestern Syria region (11). The number of vaccinated healthcare workers is low despite the high risk.…”

Section: Discussionmentioning

confidence: 99%

Kuzeybatı Suriye'de COVID-19 aşısı ile ilk aşılanan sağlık çalışanlarının değerlendirilmesi: Acil servislerde aşı yan etkisi gözlemleri

Karaca

ÇELİK

2022

Genel Tıp Dergisi

Self Cite

View full text Add to dashboard Cite

Aim In this study, we investigated the adverse effects of the COVID-19 vaccine administered to health workers in northwestern Syria. Materials and Methods The study retrospectively analyzed data from 260 health care workers who received the first dose of COVID-19 vaccine between May 1, 2021, and June 30, 2021, in the northwestern Syria region by searching the Syrian Immunization Group database (SIG) and patient records from hospital or health center emergency departments. Results The mean age of health care personnel was 35.86∓8.03 years, and 9.6% were women. Of those who participated in the study, 5.8% had comorbid diseases. 109 (42.1%) were vaccinated in hospital emergency departments and 151 (57.9%) in health center emergency departments. It was found that 63.5% (n=165) of those vaccinated experienced adverse reactions to the Oxford/AstraZeneca vaccine. The most common adverse reactions to the vaccine were fever in 128 individuals (49%), fatigue in 89 individuals (55.6%), headache in 54 individuals (20.8%), weakness in 53 individuals (20.4%), joint pain in 50 individuals (19.2%), injection site pain in 47 individuals (18.1%), and muscle pain in 33 individuals (12.7%). The side effects noted were classified as severe, moderate, and mild. Of these, fever 15.4% (n=40), fatigue 11.9% (n=31), and headache 9.6% (n=25) were the most common severe side effects. It was found that 14 (5.4%) individuals required hospitalization and medical treatment due to adverse reactions to the vaccine. When evaluating the side effects observed in hospitalized patients, the most common side effects were fever, chills, muscle pain, joint pain, fatigue, and weakness. Conclusion It was concluded that the Oxford/AstraZeneca vaccine administered to health care workers in northwestern Syria had no fatal side effects and that fewer side effects were generally observed in this study compared with the literature. Research on side effects through independent studies will help address global and regional concerns about vaccines.

show abstract

“…3 COVID-19 bulaş riski sağlık kurumlarının temel taşı olan sağlık çalışanlarına salgınla mücadeleyi daha da zorlu hâle getirmiştir. 4 Bulaş ve maruz kalma riskinin en yüksek olduğu alanların, sağlık hizmeti verilen kurumlar olduğu kabul edilmiştir. Bu nedenle sağlık çalışanları COVID-19 hastalığı için risk altında olup aynı zamanda hastalığı yayma potansiyeli de mevcuttur.…”

unclassified

“…15 Araştırmacılar tarafından literatür taranarak oluşturulmuş olan 20 soruluk anket formu, araştırmaya katılmayı kabul eden sağlık çalışanlarına, Google-Formlar (Alphabet Inc., ABD)anket üzerinden uygulandı. 1,4,10,11 Tablo 1'de gösterildiği üzere, COVID-19 geçiren sağlık personelinin aşı olma durumuna göre demografik verileri karşılaştırıldığında; hastalığı geçiren 310 sağlık personelinden, 18-25 yaş aralığında olan 21 personelin tamamının (%100) aşı olduğu gözlendi. Aşı olan 282 sağlık personelin 193'ü (%68,4) kadın cinsiyet olmakla beraber cinsiyet ile aşı olma arasında anlamlı bir ilişki saptanmadı (p>0,05).…”

unclassified

The Evaluation for Before and After Vaccination of the Healthcare Staff Has COVID-19: Cross-Sectional Study

KÖKSAL,

BÖLÜK,

GÖÇMEN

et al. 2023

Turkiye Klinikleri J Nurs Sci

View full text Add to dashboard Cite

Bu çalışmanın amacı; koronavirüs hastalığı-2019 [coronavirus disease-2019 (COVID-19)] geçiren sağlık personelinin demografik özellikleri ile COVID-19 aşı olma durumunu karşılaştırarak, COVID-19 aşısının etkinliğini belirlemektir. Gereç ve Yöntemler: Çalışmaya; 1 Mart 2020-1 Nisan 2022 tarihleri arasında hastanede aktif olarak çalışan 875 sağlık çalışanından, COVID-19 polimeraz zincir reaksiyonu (+) tanısı alan 310 sağlık çalışanı dâhil edildi. Çalışma, toplam 17 sorudan oluşan anket formu kullanılarak yapıldı ve Google anket yöntemi kullanılarak veriler toplandı. Verilerin değerlendirilmesinde, Mann-Whitney U testi, karşılaştırılmasında ise ki-kare testi kullanıldı. Bulgular: COVID-19 geçiren katılımcıların %91'i COVID-19 aşısı olmuş olup, %40,6'sı 36-45 yaş aralığında, %68,4'ü kadın cinsiyette ve %75,8'inin kronik hastalığının olmadığı tespit edildi. En fazla görülen belirtiler sırasıyla hâlsizlik, eklem ağrısı, boğaz ağrısı, öksürük ve baş ağrısı olduğu belirlendi. COVID-19 aşısı olmadan önce ve olduktan sonraki belirtiler arasında anlamlı fark gözlenmedi (p>0,05). İki BioNTech ve fazlasını olan sağlık çalışanlarının daha az (%1,3) COVID-19 geçirdiği tespit edildi. COVID-19 geçirirken ilaç kullananlarla kullanmayanların iyileşme süreleri karşılaştırıldığında, ilaç kullananların 3-5 gün arasında iyileştiği görüldü (p<0,05). Sonuç: 2020-2022 yılları arasında COVID-19 geçiren sağlık personelinin verilerine bakıldığında, aşı olma durumunun semptomlarda önemli değişiklik yaratmadığı fakat 2 BioNTech ve daha fazlası aşı olmanın, antiviral ve antibiyotik ilaç kullanımının iyileşme süresine katkısı olduğu sonucuna varıldı. Anah tar Ke li me ler: COVID-19 aşısı; sağlık personeli; demografi ABS TRACT Objective: The aim of this study, it is to determine the determination of the coronavirus disease-2019 (COVID-19) vaccine by comparing the demographic characteristics of healthcare personnel who have had COVID-19 and the status of being vaccinated against COVID-19. Material and Methods: Study; Between March 1, 2020and April 1, 2022, 310 healthcare professionals who were diagnosed with COVID-19 polymerase chain reaction (+) were included out of 875 healthcare professionals actively working at the hospital. The study was conducted using a questionnaire consisting of 17 questions in total, and data were collected using the Google Survey method. Data; The Mann-Whitney U test was analyzed with the chi-square test. Results: 91% of the participants who had COVID-19 were vaccinated against COVID-19, 40.6% were between the ages of 36-45, 68.4% were female, and 75.8% had no chronic disease. The most common symptoms were fatigue, joint pain, sore throat, cough and headache, respectively. No significant difference was observed between the symptoms before and after the COVID-19 vaccine (p>0.05). It was found that healthcare workers with two BioNTechs or more, had less COVID-19 (1.3%). Comparing the recovery times of those who used drugs and those who did not while they had COVID-19, it was seen that those who used drugs statistically rec...

show abstract

Evaluation of demographic and clinical characteristics of healthcare professionals with COVID-19 in Northwest Syria Region

Cited by 6 publications

References 0 publications

Dialysis Requirements of Kidney Transplant Recipients During COVID-19

Dialysis Requirements of Kidney Transplant Recipients During COVID-19

Kuzeybatı Suriye'de COVID-19 aşısı ile ilk aşılanan sağlık çalışanlarının değerlendirilmesi: Acil servislerde aşı yan etkisi gözlemleri

The Evaluation for Before and After Vaccination of the Healthcare Staff Has COVID-19: Cross-Sectional Study

Contact Info

Product

Resources

About